The impact of topical finasteride on male-pattern baldness

Effect of topical finasteride on treatment of patients with androgenic alopecia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201202048917N1

Enrollment

Registered

2012-03-10

Start date

2011-06-30

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic alopecia. Androgenic alopecia

Interventions

Administeration of topical finasteride 2% solution for all the patients for a 12-month period to be used on the skulp skin with hair loss once each night..

Treatment - Drugs

Administeration of topical finasteride 2% solution for all the patients for a 12-month period to be used on the skulp skin with hair loss once each night.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criterion: (to have androgenic alopecia of any type) Exclusion criteria: (to be pregnant; to have non-androgenic alopecia in other regions of the body; to have signs of allergy to finasteride)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Number of lost hair. Timepoint: Before the initiation of the treatment and 3, 6, 9 and 12 month after the initiation of the treatment. Method of measurement: Using hair loss test.;Hair diameter. Timepoint: Before the initiation of the treatment and 3, 6, 9 and 12 month after the initiation of the treatment. Method of measurement: Using a micrometer under a microscope.;Type of androgenic alopecia. Timepoint: Before the initiation of the treatment and 3, 6, 9 and 12 month after the initiation of the treatment. Method of measurement: Based on protocol.	—

Measure

Time frame

Number of lost hair. Timepoint: Before the initiation of the treatment and 3, 6, 9 and 12 month after the initiation of the treatment. Method of measurement: Using hair loss test.;Hair diameter. Timepoint: Before the initiation of the treatment and 3, 6, 9 and 12 month after the initiation of the treatment. Method of measurement: Using a micrometer under a microscope.;Type of androgenic alopecia. Timepoint: Before the initiation of the treatment and 3, 6, 9 and 12 month after the initiation of the treatment. Method of measurement: Based on protocol.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJavad Shokri

Tabriz Medical University

shokri.j@gmail.com+98 41 1337 2583

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026